Navigation Links
Allscripts Announces Final Tax Treatment of Special Cash Dividend From the Transactions With Misys plc Completed in October 2008
Date:4/9/2009

CHICAGO, April 9 /PRNewswire-FirstCall/ -- Allscripts-Misys Healthcare Solutions, Inc. ("Allscripts") announced today information related to the federal income tax treatment of the special dividend of $5.23 per share distributed in connection with the transactions Allscripts consummated with Misys plc on October 10, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO)

At the time of the special dividend, Allscripts disclosed that in general the special dividend would be taxable as a dividend to the extent of current and accumulated earnings and profits of legacy Allscripts Healthcare Solutions, Inc. through December 31, 2008, but that the amount of such earnings and profits could not be determined until after the end of 2008. Allscripts has now completed its review of Allscripts earnings and profits and has determined that, of the special cash dividend of $5.23 per share, the first 10.28%, or approximately $0.54 per share, is taxable as a dividend. Thereafter, the special cash dividend will generally be treated as a tax-free return of capital that reduces a stockholder's tax basis in its shares of Allscripts common stock to the extent of such tax basis and, after such basis has been reduced to zero, taxable as gain from the sale or exchange of Allscripts common stock. As required by applicable regulations, the special cash dividend had previously been reported on IRS Form 1099 as being entirely taxable. Amended IRS Forms 1099 to reflect this final tax treatment will be distributed.

The tax treatment of the special cash dividend will depend on the individual circumstances of each stockholder and stockholders are urged to seek advice from their tax advisor. For additional information on the tax treatment of the special cash dividend, you may refer to the section of the definitive proxy statement filed by Allscripts with the Securities and Exchange Commission on August 21, 2008 entitled "Material U.S. Federal Income Tax Consequences of the Transactions" beginning on page 64 of such proxy statement.

About Allscripts

Allscripts (Nasdaq: MDRX) uses innovation technology to bring health to healthcare. More than 150,000 physicians, 700 hospitals and nearly 7,000 post-acute and homecare organizations utilize Allscripts to improve the health of their patients and their bottom line. The company's award-winning solutions include electronic health record, electronic prescribing, revenue cycle management, practice management, document management, medication services, hospital care management, emergency department information systems and homecare automation. Allscripts is the brand name of Allscripts-Misys Healthcare Solutions, Inc. To learn more, visit www.allscripts.com.


'/>"/>
SOURCE Allscripts
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Allscripts Named to FORTUNE 100 Fastest-Growing Companies List
2. West Penn Allegheny Health System Selects Electronic Health Record From Allscripts
3. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
4. Allscripts Featured in Microsoft HealthVault Worldwide Launch
5. Lakeside Systems Selects Allscripts Electronic Health Record for 100 Physicians
6. Allscripts to Announce Third Quarter 2007 Results on November 8th
7. Allscripts Reports Third Quarter 2007 Results
8. Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report
9. Allscripts Adds TeamPraxis Quality Reporting Software for Electronic Health Records
10. ProHealth Physicians Selects Allscripts Electronic Health Record and Practice Management for 240 Providers
11. Mankato Clinic Selects Allscripts Electronic Health Record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article ... ancient teeth, which reveal a great deal about prehistoric ice-age dental practitioners and their ... have been used to remove decayed dental matter, and that teeth were then filled ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... ... professor Christopher Salas-Wright finds that youth violence is declining—and at noteworthy rates. Between ... relative proportion of young people involved in violence in the United States. The ...
(Date:4/21/2017)... ... April 21, 2017 , ... Brady (NYSE:BRC), a ... B-595 and B-7569 vinyl label materials received certification for the ... are tested to remain intact and legible, for use on chemical drums shipped by ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... The adage ... Flex House, the next project in the company’s esteemed VISION House demonstration project series. ... use exactly the amount of resources they need to live affordably and abundantly without ...
(Date:4/21/2017)... ... 21, 2017 , ... The Hong Kong Polytechnic University (PolyU) launched today the ... education institutions in Hong Kong to support teaching, learning and research. It is also ... of facilities in Hong Kong. , With an area of 620 square metres ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... 1 fiscal 2017 earnings per share (EPS) guidance ... 2019.  This is in conjunction with this morning,s announcement ... Vein Thrombosis and Nutritional Insufficiency businesses. Cardinal ... continuing operations will be at the bottom of its ...
Breaking Medicine Technology: